This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2025. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
| Item | Value |
|---|---|
| Country | |
| Facebook page | CIDResearch |
| Website | http://www.seattlebiomed.org/ |
| Twitter username | CIDResearch |
| Wikipedia page | https://en.wikipedia.org/wiki/Center_for_Infectious_Disease_Research |
| Instagram username | cidresearch |
| Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 44 | 500,000 | 1,679,482 | -1,932,868 | 0 | 500 | 10,000 | 150,000 | 500,000 | 711,972 | 1,024,815 | 2,970,000 | 4,399,331 | 19,366,967 |
| Global health | 43 | 556,555 | 1,718,191 | -1,932,868 | 0 | 500 | 9,500 | 192,213 | 556,555 | 711,972 | 1,043,390 | 2,970,000 | 4,399,331 | 19,366,967 |
| FIXME | 1 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 |
| Donor | Total | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 1990 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation (filter this donee) | 73,882,211.31 | -374,009.00 | 5,500.00 | 8,500.00 | -1,262,114.34 | 5,157,769.00 | 1,769,910.00 | 10,528,895.00 | 3,559,859.00 | 6,096,103.65 | 2,322,819.00 | 17,540,199.97 | 28,528,779.03 | 0.00 |
| MacArthur Foundation (filter this donee) | 15,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15,000.00 |
| Total | 73,897,211.31 | -374,009.00 | 5,500.00 | 8,500.00 | -1,262,114.34 | 5,157,769.00 | 1,769,910.00 | 10,528,895.00 | 3,559,859.00 | 6,096,103.65 | 2,322,819.00 | 17,540,199.97 | 28,528,779.03 | 15,000.00 |
There are no documents associated with this donee.
Graph of top 10 donors (for donations with known year of donation) by amount, showing the timeframe of donations
| Donor | Amount (current USD) | Amount rank (out of 44) | Donation date | Cause area | URL | Influencer | Notes |
|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | -374,009.00 | 43 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | for the analysis of samples and data from Scientific Advisory Board-approved vaccine trials and natural history studies, in order to, as part of a Systems Biology/ Systems Immunology Consortium, uncover signatures, correlates, and mechanisms of protectio; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 5,000.00 | 34 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to provide for general operating support. 2016 Annual Gala for Global Health. Investment start date: 2/17/2016 to end date: 3/18/2016. Grantee name: Seattle Biomedical Research Institute; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 500.00 | 35 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide for general operating support. Starting Gates Thank You December 2015. Investment start date: 1/6/2016 to end date: 1/7/2016. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected countries: United states of america (the). | |
| Bill and Melinda Gates Foundation | 500.00 | 35 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | To provide for general operating support. Starting Gates 4/8/2015. Investment start date: 9/30/2015 to end date: 10/29/2015. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected countries: United states of america (the). | |
| Bill and Melinda Gates Foundation | 7,500.00 | 33 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to provide general operating support. 2015 Gala for Global Health. Investment start date: 8/25/2015 to end date: 9/18/2015. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 500.00 | 35 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to support the Starting Gates partnership. Starting Gates 10/15/14. Investment start date: 1/21/2015 to end date: 2/5/2015. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected countries: United states of america (the). | |
| Bill and Melinda Gates Foundation | -341,059.34 | 42 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to identify biomarkers of correlates of protection against pre-erythrocytic (PE) malaria infection that will enable down selection of vaccine antigens and predict outcomes of trials for anti-infection vaccines against Plasmodium falciparum; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -41,577.00 | 40 | Global health/Medical research | https://iatiregistry.org/publisher/bmgf | -- | to support the Global Health Research Congress. Global Health Research Congress. Investment start date: 10/14/2009 to end date: 5/9/2014. Grantee name: Seattle Biomedical Research Institute; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,043,390.00 | 13 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to support the general operations of Seattle Biomedical Research Institute. General Operating Support. Investment start date: 5/1/2014 to end date: 12/31/2016. Grantee name: Seattle Biomedical Research Institute; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -1,932,868.00 | 44 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to identify biomarkers of correlates of protection against pre-erythrocytic (PE) malaria infection that will enable down selection of vaccine antigens and predict outcomes of trials for anti-infection vaccines against Plasmodium falciparum; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 10,000.00 | 31 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | for general operating support. 2014 Passport to Global Health Celebration. Investment start date: 2/13/2014 to end date: 3/7/2014. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected countries: United states of america (the). | |
| Bill and Melinda Gates Foundation | 4,399,331.00 | 5 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | for the analysis of samples and data from Scientific Advisory Board-approved vaccine trials and natural history studies, in order to, as part of a Systems Biology/ Systems Immunology Consortium, uncover signatures, correlates, and mechanisms of protectio; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 500.00 | 35 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | for general operating support. StartingGates 9/17/2013. Investment start date: 9/26/2013 to end date: 10/25/2013. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected countries: United states of america (the). | |
| Bill and Melinda Gates Foundation | 757,938.00 | 17 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to develop methodology with the goal of identifying novel antigens that can induce sterile, long-lasting protection against malaria liver stage and thus infection; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 764,952.00 | 16 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to facilitate identification of correlates of vaccine-induced immunity and (eventually) protection from TB, enabling iterative design of improved TB vaccines that will play a critical role in the fight to end this deadly disease.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 448,403.00 | 24 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | for proteomic identification of novel surface and secreted antigens as targets to block malaria infection.; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 556,555.00 | 22 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to develop methodology with the goal of identifying further novel antigens that can induce sterile, long-lasting protection against malaria liver stage and thus infection; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 1,203,410.00 | 12 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to determine whether wild-type liver stage P. falciparum parasites can induce anti-infection immunity in humans if killed prior to the formation, and release of blood-stage parasites; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 379,820.00 | 25 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to develop tools that will enable the study of Plasmodium vivax malaria. Development of gametocyte and liver stage specific markers for Plasmodium vivax. Investment start date: 10/31/2011 to end date: 6/30/2014. Grantee name: Seattle Biomedical Research I; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 8,945,665.00 | 3 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to identify biomarkers of correlates of protection against pre-erythrocytic (PE) malaria infection that will enable down selection of vaccine antigens and predict outcomes of trials for anti-infection vaccines against Plasmodium falciparum; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 711,971.80 | 18 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to develop the knowledge which is needed to develop vaccines and drugs for global infectious diseases including malaria, tuberculosis, HIV/AIDS, and emerging and neglected diseases; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: South of Sahara|Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 711,971.80 | 18 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to develop the knowledge which is needed to develop vaccines and drugs for global infectious diseases including malaria, tuberculosis, HIV/AIDS, and emerging and neglected diseases; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: South of Sahara|Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 711,971.80 | 18 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to develop the knowledge which is needed to develop vaccines and drugs for global infectious diseases including malaria, tuberculosis, HIV/AIDS, and emerging and neglected diseases; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: South of Sahara|Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,423,943.60 | 11 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop the knowledge which is needed to develop vaccines and drugs for global infectious diseases including malaria, tuberculosis, HIV/AIDS, and emerging and neglected diseases; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: South of Sahara|Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 3,005,236.00 | 7 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to determine whether wild-type liver stage P. falciparum parasites can induce anti-infection immunity in humans if killed prior to the formation, and release of blood-stage parasites; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 150,000.00 | 27 | Global health/Medical research | https://iatiregistry.org/publisher/bmgf | -- | to support the Global Health Research Congress. Global Health Research Congress. Investment start date: 10/14/2009 to end date: 5/9/2014. Grantee name: Seattle Biomedical Research Institute; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -63,225.35 | 41 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support the "Diagnosing pregnancy malaria: Detecting infection, predicting disease" conference; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 2,994,593.00 | 8 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to fight tuberculosis by forging new ways to develop antibiotics that dramatically shorten therapy; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 9,500.00 | 32 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | for general operating support. for general operating support. Investment start date: 3/17/2009 to end date: 3/17/2010. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 559,712.00 | 21 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to enhance the sustainability of SBRI's global health discovery and translational research for the alleviation of global infectious diseases; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,024,815.00 | 14 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to develop new opportunities to identify and validate new targets for anti-malarial drugs; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 500,000.00 | 23 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to increase student awareness of global health issues and inspire them to enter global health fields; Aid type: Project-type interventions. Affected countries: United states of america (the). | |
| Bill and Melinda Gates Foundation | 118,059.00 | 29 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support the "Diagnosing pregnancy malaria: Detecting infection, predicting disease" conference; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 120,233.00 | 28 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to support planning activities for the Global Health Research Congress. Global Health Research Congress Planning Grant. Investment start date: 3/22/2008 to end date: 8/21/2009. Grantee name: Seattle Biomedical Research Institute; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 8,998,623.00 | 2 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to develop immunogens for a vaccine that will prevent pregnancy malaria globally. Pregnancy Malaria Initiative. Investment start date: 10/1/2007 to end date: 4/30/2014. Grantee name: Seattle Biomedical Research Institute; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 1,021,400.97 | 15 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to plan a Worldwide Antimalarial Drug Resistance Network (WARN) as a global resource to ensure efficacious use of antimalarial drugs; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 7,520,176.00 | 4 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to fight tuberculosis by forging new ways to develop antibiotics that dramatically shorten therapy; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 192,213.00 | 26 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to fund a meeting to initiate creation of a public, web-based database of current and historical patterns of drug resistance in malaria parasites; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | -30,400.97 | 39 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to fund a meeting to initiate creation of a public, web-based database of current and historical patterns of drug resistance in malaria parasites; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 3,060,000.00 | 6 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | for general operating support. Expansion Activities. Investment start date: 7/24/2006 to end date: 7/31/2012. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,970,000.00 | 9 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | for general operating support. Expansion Activities. Investment start date: 7/24/2006 to end date: 7/31/2012. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,970,000.00 | 9 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | for general operating support. Expansion Activities. Investment start date: 7/24/2006 to end date: 7/31/2012. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 19,366,967.00 | 1 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to use novel computational and biological approaches for the design and evaluation of HIV vaccine candidates; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| MacArthur Foundation | 15,000.00 | 30 | FIXME | https://www.macfound.org/grants/ | -- | For a workshop on the molecular biology of leishmaniasis and trypanosomiases. Affected countries: United States; affected states: Washington; affected cities: Seattle. |